ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
JSE Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group” or “the Company”)



RELEASE OF ANNUAL FINANCIAL STATEMENTS, CHANGE STATEMENT AND NOTICE OF ANNUAL
GENERAL MEETING ON 8 DECEMBER 2022

RELEASE OF ANNUAL FINANCIAL STATEMENTS

Shareholders are advised that the Company’s audited annual financial statements for the year ended
30 June 2022 is available on the Company’s website, www.aspenpharma.com/investor-information/,
from today, 4 October 2022.
The annual financial statements were audited by the Company’s external auditors, Ernst & Young Inc.,
and the unmodified report is available for inspection at the Company’s registered office.

CHANGE STATEMENT

The audited annual financial statements (“Audited”) contain a change to the reviewed provisional
Group financial results (“Reviewed”) for the year ended 30 June 2022, as released on the JSE Stock
Exchange News Service on 31 August 2022. This change is reflected as follows:

                                                   Reviewed      Change              Audited
                                                   (R’m)         (R’m)               (R’m)
 Total Non-current liabilities                     18 338        (1 300)             17 038
 Total Current liabilities                         22 095        1 300               23 935

 Non-current portion of borrowings                 11 882        (1 300)             10 582
 Current portion of borrowings                     10 365        1 300               11 665

 Total liabilities                                 40 433        -                   40 433
 Total borrowings                                  22 247        -                   22 247

 Amounts to be refinanced (refer to note G)        8 400         -                   8 400
 Cash utilised in financing activities             (4 674)       -                   (4 674)
 Net borrowings (R’m)                              16 064        -                   16 064

 Leverage ratio (times)                            1.9           -                   1.9

Included in the audited current borrowings of R11.7 billion is syndicated bank debt to the value of R8,4
billion, which matures on 1 July 2023 (the “Maturing Facilities”).
The net adjustment principally relates to the disclosure of an amount repayable on 1 July 2023, as a
short-term borrowing.
As previously reported, the Group has commenced a process to refinance the Maturing Facilities
through new syndicated bank debt facilities of similar commercial terms, value, tenor, currency
composition and lender composition as the Maturing Facilities (“New Facilities”). It is intended that the
New Facilities will be in place before the end of November 2022.

NOTICE OF THE ANNUAL GENERAL MEETING

The annual general meeting will be held on Thursday, 8 December 2022 at 10:00 at Aspen’s head
office (Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge in Durban), to transact
the business as stated in the notice of the annual general meeting.
The record date to participate and vote at the annual general meeting will be Friday, 2 December 2022
and the last day to trade to be eligible to vote and participate at the annual general meeting will be
Tuesday, 29 November 2022.

Aspen’s 2022 integrated report will be made available on the Company’s website at the end of
October 2022, with a JSE SENS announcement being released to notify shareholders in this regard. The
notice and proxy of the annual general meeting will be posted to shareholders at this time, together
with the summarised audited Group annual financial statements.



Durban
4 October 2022

Sponsor
Investec Bank Limited